Development and Validation of Flow Cytometry Methods for Pharmacodynamic Clinical Biomarkers

• Biomarkers Definitions Working Group (NIH). Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin. Pharmacol. Ther. 69, 89–95 (2001).
   PubMed Web of Science ®Google Scholar
• Lee WL , WeinerES, SailstadJMet al. Method validation and measurement of biomarkers in nonclinical and clinical samples in drug development: a conference report. Phar. Res. 22(4), 499–511 (2005).
   Google Scholar
• Robinson P , DarzynkiewiczZ, DeanPNet al. Current Protocols in Cytometry . John Wiley and Sons, NY, USA (2009).
   Google Scholar
• Gratama JW , OrfaoA, BarnettDet al. Flow cytometric enumeration of CD34+ hematopoietic stem and progenitor cells. Cytometry34, 128–142 (1998).
   PubMedGoogle Scholar
• Calvelli T , DennyTN, PaxtonHet al. Guideline for flow cytometric immunophenotyping: a report from the National Institute of Allergy and Infectious Diseases, Division of AIDS. Cytometry14, 702–714 (1993).
   PubMedGoogle Scholar
• Cunliffe J , DerbyshireN, KeelerS, ColdwellR. An Approach to the validation of flow cytometry methods. Pharm. Res. 22(12), 2551–2557 (2009).
   Google Scholar
• Lee JW , DevanarayanV, BarrettYCet al. Fit-for-purpose method development and validation for successful biomarker measurement. Pharm. Res. 23(2), 312–328 (2006)
   PubMed Web of Science ®Google Scholar
• Kruisbeek A , ShevachE, ThortonA. Proliferative assays for T cell function. In:Current Protocols in Immunology. Coico R (Ed.) John Wiley and Sons, NY, USA, 3, 12 (2004).
   Google Scholar
• Arkin CF , DavisBH, BessmanJDet al. Approved Guideline – Second Edition. Methods for reticulocyte counting (automated blood cell counters, flow cytometry and supravital dyes) . Clinical and Laboratory Standards Institute (Volume 24), H44–A2 (2004).
   Google Scholar
• Stetler-Stevenson M , AhmadE, BarnettDet al. Approved Guideline – Second Edition. Clinical flow cytometric analysis of neoplastic hematolymphoid cells. Clinical and Laboratory Standards Institute (Volume 27), H43–A2 (2007).
   Google Scholar
• Krutzik PO , IrishJM, NolanGP, PerezOD. Analysis of protein phosphorylation and cellular signaling events by flow cytometry; techniques and clinical applications. Clin. Immunol. 110, 206–221 (2004).
   PubMed Web of Science ®Google Scholar
• Chau CH , RixeO, McLeodH, FiggW. Validation of analytic methods for biomarkers used in drug development. Clin. Cancer Res. 14(19), 5967–5976 (2008).
   PubMed Web of Science ®Google Scholar
• Reimann KA , ChernoffM, WilkeningCL, NickersonCE, LandayAL. The ACTG Immunology Advanced Technology Laboratories. Preservation of lymphocyte immunophenotype and proliferative responses in cryopreserved peripheral blood mononuclear cells from human immunodeficiency virus type 1-infected donors: implications for multicenter clinical trials. Clin. Diag. Lab. Immunol. 7(3), 352–359 (2000).
   PubMedGoogle Scholar
• Maecker HT , MoonJ, BhatiaSet al. Impact of cryopreservation on tetramer, cytokine flow cytometry, and ELISPOT. BMC Immunol. 6, 17 (2005).
   PubMed Web of Science ®Google Scholar
• Patti-Diaz L , WuYD. Development of a flow cytometric assay to evaluate naive and memory T cell populations in human peripheral blood mononuclear cells. Presented at:ISAC XXIII International Congress. Quebec City, QC, Canada, 20–26 May 2006.
   Google Scholar
• Disis M , dela Rosa C, Goodell Vet al. Maximizing the retention of antigen specific lymphocyte function after cryopreservation. J. Immunol. Meth. 308, 13–18 (2006).
   PubMed Web of Science ®Google Scholar
• Ruitenberg JJ , MulderCB, MainoVC, LandayAL, GhanekarSA. Vacutainer® CPT® and ficoll density gradient separation perform equivalently in maintaining the quality and function of PBMC from HIV seropositive blood samples. BMC Immunol. 7, 11 (2006).
   PubMed Web of Science ®Google Scholar
• Bull M , LeeD, StuckyJ, ChiuY, RubinA, HortonH, McElrathMJ. Defining blood processing parameters for optimal detection of cryopreserved antigen-specific responses for HIV vaccine trials. J. Immun. Methods322-(1–2), 57–69. (2007)
   PubMed Web of Science ®Google Scholar
• Cosentino LM , CorwinW, BaustJMet al. Preliminary report: evaluation of storage conditions and cryococktails during peripheral blood mononuclear cell cryopreservation. Cell Preserv. Technol. 5(4), 189–204 (2007).
   Google Scholar
• Weinberg A , ZhangL, BrownDet al. Viability and fnctional activity of cryopreserved mononuclear cells. Clin. Diag. Lab. Immunol. 7(4), 714–716 (2000).
   PubMedGoogle Scholar
• Green L , MarderP, RayCet al. Development and validation of a drug activity biomarker that shows target inhibition in cancer patients receiving enzastaurin, a novel protein kinase C-β inhibitor. Clin. Cancer Res. 12(11), 3409–3415 (2006).
   Web of Science ®Google Scholar
• Chattopadhyay PK , HogerkorpCM, RoedererM. A chromatic explosion: the development and future of multiparameter flow cytometry. Immunology125(4), 441–449 (2008).
   PubMed Web of Science ®Google Scholar
• Horton H , ThomasEP, StuckyJAet al. Optimization and validation of an 8-color intracellular cytokine staining (ICS) assay to quantify antigen-specific T cells induced by vaccination. J. Immunol. Meth. 323, 39–54 (2007).
   PubMed Web of Science ®Google Scholar
• Wu D . Standardization of a flow cytometry assay to measure protein expression on monocytes in human whole blood. Presented at:AAPS National Biotechnology Conference, San Diego, CA, USA, 24–27 June 2007.
   Google Scholar
• Mahnke Y , RoedererM. Optimizing a multi-color immunophenotyping assay. Clin. Lab. Med. 27(3), 469 (2007).
   PubMed Web of Science ®Google Scholar
• Wood BL . Ten-color immunophenotyping of hematopoietic cells. In:Current Protocols in Cytometry. Robinson JP (Ed.), John Wiley and Sons, NY, USA, 6.21.1–6.21.4 (2005).
   Google Scholar
• Stelzer GT , MartiG, HurleyA, McCoyP, LovettEJ, SchwartzA. U.S.–Canadian consensus recomemendations on the immunophenotypic analysis of hematologic neoplasia by flow cytometry: standardization and validation of laboratory procedures. Cytometry30, 214–230 (1997).
   PubMedGoogle Scholar
• Roederer M . Spectral compensation for flow cytometry: visualization artifacts, limitations, and caveats. Cytometry45, 194–205 (2001).
   PubMedGoogle Scholar
• Purvis N , StelzerG. Multi-platform, multi-site instrumentation and reagent standardization. Cytometry33, 156–165 (1998).
   PubMedGoogle Scholar
• Maecker HT , TrotterJ. Flow cytometrty controls, instrument setup and determination of positivity. Cytometry69, 1037–1042 (2006).
   PubMedGoogle Scholar
• Stewart CC , StewartSJ. Titering antibodies. In:Current Protocols in Cytometry. Robinson JP (Ed.), John Wiley and Sons, NY, USA, 4.1.1–4.1.13 (1997).
   Google Scholar
• BD Biosciences Technical Bulletin: Introduction to compensation for multicolor assays on digital flow cytometers. BD Biosciences (2009).
   Google Scholar
• Tung JW , ParksDR, MooreWA, HerzenbergLA, HerzenbergLA. New approaches to fluorescence compensation and visualization of FACS data. Clin. Immnol. 110, 277–283 (2004).
   PubMed Web of Science ®Google Scholar
• Latek R , FleenerC, LamianVet al. Assessment of belatacept-mediated costimulation blockade through evaluation of CD80/86-receptor saturation. Transplantation87(6), 926–933 (2009)
   PubMed Web of Science ®Google Scholar
• Schwartz A , GaigalasAK, WangL, MartiGE, VogtRF, Fernandez-RepolletE. Formalization of the MESF unit of fluorescence intensity. Cytometry B57B, 1–6 (2004).
   Google Scholar
• Hilt E , FleenerC, RobinsonDet al. Fit-for-purpose method validation for a flow cytometry-based CD86 receptor competition assay to measure receptor saturation by belatacept (BMS-224818; LEA29Y). Presented at:AAPS National Biotechnology Conference, San Diego, CA, USA, 24–27 June 2007.
   Google Scholar
• Mittag A , TarnokA. Basics of standardization and calibration in cytometry – a review. J. Biophotonics (8–9), 470–481 (2009).
   PubMed Web of Science ®Google Scholar
• Wyant T , LackeyA, GreenM. Validation of a flow cytometry based chemokine internalization assay for use in evaluating the pharmacodynamic response to a receptor antagonist. J. Transl. Med. 6, 76 (2008).
   PubMed Web of Science ®Google Scholar
• Cummings J , WardTH, GreystokeA, RansonM, DiveC. Biomarker method validation in anticancer drug development. Br. J. Pharmacol. 153, 646–656 (2008).
   PubMed Web of Science ®Google Scholar
• Weinberg A , SongL, WilkeningCet al. Optimization and limitations of use of cryopreserved peripheral blood mononuclear cells for functional and phenotypic T-cell characterization. Clin. Vaccine Immunol. 16(8), 1176–1186 (2009).
   PubMed Web of Science ®Google Scholar
• Maecker HT , Hassler,J, PayneJet al. Precision and linearity targets for validation of an IFNγ elispot, cytokine flow cytometry and tetramer assay using CMV peptides. BMC Immunol. 9, 9 (2008).
   PubMed Web of Science ®Google Scholar
• Ezzelle J , Rodriguez-ChavezIR, DardenJMet al. Guidelines on good clinical laboratory practice: bridging operations between research and clinical research laboratories. J. Pharm. Biomed. Anal. 46(1), 18–29 (2008).
   PubMed Web of Science ®Google Scholar
• Wood JCS , HoffmanRA. Evaluating fluorescence sensitivity on flow cytometers: an overview. Cytometry33, 256–259 (1998).
   PubMedGoogle Scholar
• Stall A Qr and Br in BD FACSDiva v6 Software; parameters for characterizing detector performance. BD Biosciences Application Note (2008).
   Google Scholar
• Wood JCS . Establishing and maintaining system linearity. In: Current Protocols in Cytometry,Robinson JP (Ed.), John Wiley and Sons, NY, USA, 1.4.1–4.1.12 (1997).
   Google Scholar
• Perfetto SP , AmbrozakD, NguyenR, ChattopadhyayP, RoedererM. Quality assurance for polychromatic flow cytometry. Nat. Protoc. 1(3), 1522–1530 (2006).
   PubMed Web of Science ®Google Scholar
• Saski DT , MaeckerH, TrotterJ. Establishing optimum baseline PMT setting gain to maximize resolution on BD Bioscience digital cytometers. BD Bioscience Application Note. Part No. 23-8389-00 (2005).
   Google Scholar
• CLIA Standards, 42 CFR Part 493, Subpart K, Standard: Control procedures. 493.1256 (2005).
   Google Scholar
• CLIA Standards, 42 CFR Part 493, Subpart K, Standard: Corrective actions. 493.1282 (2005).
   Google Scholar
• Berte LM , WoodcockSM, ArendashE, AzarM, RabinovitchA, StokeldTD. Approved Guideline – Second Edition. Training and Competence Assessment. Clinical and Laboratory Standards Institute (Volume 24) GP21-A2 (2004).
   Google Scholar
• CLIA Standards, 42 CFR Part 493, Subpart J, Standard: Retention requirements. 493.1105 (2005).
   Google Scholar
• Mountain PJ , KnafelAJ, ButchSH, DunkaL, MarkinRS, O’BryanD. Approved Guideline Second Edition. Laboratory instruments and data management systems: design of software user interfaces and end-user software systems validation operation and monitoring. Clinical and Laboratory Standards Institute (23) GP19-A2 (2003).
   Google Scholar
• CLIA Standards, 42 CFR Part 493, Subpart K, Standard: Test report. 493.1291 (2005).
   Google Scholar
• Lee JA , SpidlenJ, BoyceKet al. MIFlowCyt: the minimum information about a flow cytometry experiment. Cytometry73A, 926–930 (2008).
   Google Scholar
• Spidlen J , LeifRC, MooreWet al. Gating- ML: XML-based gating descriptions in flow cytometry. Cytometry73A, 1151–1157 (2008).
   PubMedGoogle Scholar
• Qian Y , TchuvatkinaO, SpidlenJet al. FuGEFlow: data model and markup language for flow cytometry. BMC Bioinformatics10, 184 (2009).
   PubMed Web of Science ®Google Scholar

Patent

• Becton Dickinson and Company. US4190535, US4350593, US4751001, US4818418, US5053134 (2001).
   Google Scholar

Websites

• US FDA: Innovation or stagnations: challenge and opportunity on critical path to new medical products. US Department of Health and Human Services report (2004). www.fda.gov/oc/initiatives/criticalpath
   Google Scholar
• Flow Jo Compensation Overview. www.flowjo.com/v8/html/compensation.html
   Google Scholar
• De Novo FCS Express Software. www.denovosoftware.com
   Google Scholar
• Becton Dickinson FACS Diva Software www.bdbiosciences.com/instruments/software/flow/facsdiva/index.jsp
   Google Scholar
• US FDA: Guidance for Industry. Bioanalytical method validation. (2001). www.fda.gov
   Google Scholar
• Glazer B. Logistics and sample transport: overview, recommendations, validation protocol. International Society for Biological and Environmental Repositories (2009). www.isber.org
   Google Scholar
• Sphero™ Technical Note. Calibration and performance tracking of flow cytometers using Sphero™ calibration particles. STN-8 Rev C 060706. www.spherotech.com/Updated%20STN%208-21-07/STN-8%20Rev%20C.pdf
   Google Scholar
• Sphero™ Technical Note. Determining PMT linearity in flow cytometers using the Sphero™PMT quality control excel template. STN-14. www.spherotech.com/STN-14revB.pdf
   Google Scholar
• NIH Chemical Genomics Center. Immunoassay methods www.ncgc.nih.gov/guidance/section10.html
   Google Scholar
• De Novo Software Data Services. www.denovosoftware.com/site/dataservices.shtml
   Google Scholar
• LabKey Software. www.labkey.com
   Google Scholar